about
Cancer genome landscapesTrial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesDDX3, a potential target for cancer treatmentTargeting the Checkpoint to Kill Cancer CellsMicroRNAs, cancer and ionizing radiation: Where are we?Cell cycle progression by the repression of primary cilia formation in proliferating cellsCancer's Achilles' Heel: Apoptosis and Necroptosis to the Rescue4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathwayStudy of Malformin C, a Fungal Source Cyclic Pentapeptide, as an Anti-Cancer DrugAnd-1 coordinates with CtIP for efficient homologous recombination and DNA damage checkpoint maintenanceCancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma.Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair.Genistein abrogates G2 arrest induced by curcumin in p53 deficient T47D cellsUSP17- and SCFβTrCP--regulated degradation of DEC1 controls the DNA damage responseHepatitis C virus NS2 protein inhibits DNA damage pathway by sequestering p53 to the cytoplasm.Inhibition of the PI3K/Akt/GSK3 pathway downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2/M arrest and prominently enhances induction of apoptosis.The E3 ubiquitin ligase ARIH1 protects against genotoxic stress by initiating a 4EHP-mediated mRNA translation arrest.Modelling the onset of senescence at the G1/S cell cycle checkpoint.A Model for p38MAPK-Induced Astrocyte SenescenceA novelly synthesized phenanthroline derivative is a promising DNA-damaging anticancer agent inhibiting G1/S checkpoint transition and inducing cell apoptosis in cancer cells.DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.Bmi-1: At the crossroads of physiological and pathological biology.Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo.Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpointMitochondria and familial predisposition to breast cancer.Maternal embryonic leucine zipper kinase (MELK) reduces replication stress in glioblastoma cellsOpportunities for Radiosensitization in the Stereotactic Body Radiation Therapy (SBRT) EraBRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stressGenetic causes of microcephaly and lessons for neuronal development.Proteomics insights into DNA damage response and translating this knowledge to clinical strategies.Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication.Maintenance of genomic integrity after DNA double strand breaks in the human prostate and seminal vesicle epithelium: the best and the worst.The growing complexity of HIF-1α's role in tumorigenesis: DNA repair and beyond.MicroRNAs in the ionizing radiation response and in radiotherapy.DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.Pathways for genome integrity in G2 phase of the cell cycle.The role of DNA damage responses in p53 biology.ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration.ATM/ATR-mediated phosphorylation of PALB2 promotes RAD51 function.
P2860
Q22242276-EF7AFB4E-85F1-41AC-A57D-7310BC35F56AQ26745686-3ACB480A-A944-4F90-BB22-7207BFF0B5CEQ26771812-82D70EAA-AE6E-40A4-855B-A5BDBE2AA448Q26779054-0021C4D5-4A78-42D3-BDC3-EC29E65A0288Q26795781-D5013C34-B195-4F0F-ADC2-E1A35F41DA11Q26801435-446258A8-9F16-4431-AC65-5F083541DB72Q27011729-F8CCEEE1-63B4-4449-AA00-7602887D2693Q28066868-1EB12A73-68A8-4E15-8D86-916536DC8CA2Q28385679-22A6400F-626A-43BC-8656-E01BC9213C8AQ28550735-E7E4A316-C0C6-44E5-AA84-16052B793F44Q33557795-E451C0FF-26C6-44F3-A18C-4E37BAB4857FQ33753714-D0348648-8058-43CD-9EDC-B612DDC51945Q34487607-42E01E25-4913-431D-859E-95006A7F4239Q34564108-997C0229-79ED-48C9-AA60-18558ADD105AQ34592732-72184054-234B-46C2-B8A4-64D1AEE10FF3Q34701793-976A80C2-F32A-438C-8D47-6319489C93ACQ35048469-E760F715-E567-4946-99F5-12A63864B87CQ35165148-955073CB-44B8-4403-9308-1480C22842A5Q35540742-A6D3B216-2D55-47A6-A313-97855D7478F5Q35625053-AF88354D-14AB-4A95-8C5C-B3F0AFA93421Q35847932-FC60DD4D-4DC2-4A10-AC37-C6CBA8EDAE89Q35941085-B98BC2E5-A85C-47B7-A4C6-443D8115E818Q36121000-9CE1DE8D-EB49-4460-BFA2-3EE10A94A745Q36242619-59F8061B-C17C-447E-88D8-E1E0AFFAF193Q36841814-991ECB7B-2C02-4A32-BF97-A9C023E50FA4Q36877040-1B9DA2DA-28E6-40A8-917A-B9720F196769Q37099799-F36E2B95-BEAC-464A-BECE-0B8720BB79EEQ37118895-353B7968-ECC8-49E0-B9AE-5FBE6727A244Q37126186-B1D73EAA-6069-4796-B5D5-A7DC0241EA2DQ37158051-F0F18698-91F5-4281-81C8-DFEE68A217EEQ37676851-C445A5FA-2B68-4055-9A83-6BE34FF7A2B9Q37718268-E8D12806-2A95-4554-A0BB-C7ED659C7518Q38023979-6E628362-E2C6-4A8D-BE66-7FD21BC9B50BQ38060522-BD2D9169-4F87-4FFC-892B-5E7848CAB7D7Q38085906-8527E168-D1A8-4FFF-B538-6C03582CE556Q38120311-C2CE2B53-1E2F-4AA1-8B61-831860769562Q38223676-F3AEB966-2C65-4BB8-BEEE-9CB33723F3FDQ38331206-E5BD1C72-D84B-46FD-8F5C-2AC83C362CA0Q38700525-9A829DA9-4E5C-4437-8C4E-52A22E673187Q38775360-FA71FB9D-BBC1-416D-8722-796B72998023
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Checkpoint control and cancer.
@en
Checkpoint control and cancer.
@nl
type
label
Checkpoint control and cancer.
@en
Checkpoint control and cancer.
@nl
prefLabel
Checkpoint control and cancer.
@en
Checkpoint control and cancer.
@nl
P2860
P356
P1433
P1476
Checkpoint control and cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2011.451
P407
P577
2011-10-03T00:00:00Z